Swiss Re’s $1.5 Billion Quarter Can’t Stop the Slide as Renewals Turn Sour

Swiss Re posts $1.5B net profit and 23.6% ROE, yet shares languish near 52-week lows as steep property-catastrophe reinsurance price declines and analyst skepticism cap gains.

Swiss Re delivered a blockbuster first quarter, but the market is looking past the rearview mirror. The Zurich-based reinsurer posted net profit of $1.5 billion and a return on equity of 23.6% — numbers that would typically draw applause. Instead, the stock has been plumbing levels not seen since November 2024, touching €127.00 on Thursday before a modest bounce to €128.90 on Friday. That represents a gain of 1.5% for the session, but the shares remain just 4.2% above their latest 52-week low of €123.70.

The divergence between operational strength and share price performance boils down to a single word: pricing. The mid-year renewal season, which closed on June 1, delivered steep cuts in property-catastrophe reinsurance. Guy Carpenter estimated declines of 15% to 20% across many layers, while Howden Re reported drops of up to 25% for loss-free Nat Cat programs. The pace of erosion is accelerating: January renewals saw a 14.7% drop, April came in at 16%, and the latest round pushed the market further into buyers’ territory.

Swiss Re’s response has been one of discipline rather than volume. Chief executive Andreas Berger, who had already flagged the softening environment, chose to walk away from business that did not meet internal return thresholds. The result: 67% of the treaty portfolio was renewed, but gross premium volume slipped 2% to $15 billion. The nominal price change was flat, as liability rate increases offset property declines, but the net price change stood at minus 4.4%.

That strategic restraint is earning respect from some quarters, but it has not silenced the skeptics on the sell side. A composite of ten analyst ratings compiled in early May showed a majority still at “Sell”. Among the most bearish is UBS, which on June 2 reiterated its “Sell” rating with a price target of €112. Autonomous and Keefe, Bruyette & Woods both rate the stock “Underperform” with targets of €120, while Barclays Capital wears an “Underweight” and a €113 target. All of these sit well below the current trading level, creating a ceiling on any rally.

The positive camp is not empty. Vontobel rates Swiss Re a “Buy” with a €140 target, DZ Bank is at €160, and Octavian goes to €164. This split explains why the stock has not collapsed outright: there are still bulls who believe the underlying earnings power justifies a higher multiple, especially with the dividend climbing to CHF 6.31 per share — a near-5% increase approved at the April general meeting — which at Thursday’s close translates into a 5.4% yield.

Technical indicators underscore the fragility. The relative strength index sits at 36.7, nudging toward oversold territory but not yet flashing a definitive buy signal. Over the past 30 days the stock has shed 8%, and the year-to-date loss stands at 9.9%. The 12-month decline of 15.5% leaves the shares 11% below their 200-day moving average. The pattern is clear: short-term bounces lack the momentum to break the medium-term downtrend.

The structural tension in the market adds another layer of uncertainty. Capital is abundant at a time when risk exposure is rising, inflation and interest rates are climbing, and reinsurance premiums are heading in the opposite direction. Fitch Ratings expects the softening to continue through 2026 but forecasts that return on equity will remain above the industry cost of capital. For Swiss Re, the question is whether its pricing discipline can preserve margins as competitors chase volume.

All eyes now turn to August 6, when Swiss Re releases its half-year results. The Q1 numbers were buoyed by contributions across all business lines, low natural catastrophe losses and strong investment income. Analysts will want to see whether those tailwinds persist — and whether the renewal cycle has started to bite into profitability. Until then, the stock remains suspended between a robust earnings base and a market that has turned decisively against it.